Latest News
Latest News
A New Focus for Cushing Syndrome Screening in Obesity
Cushing Syndrome screening may be best targeted to those with phenotypes known as metabolically healthy or unhealthy obesity.
Latest News
Cell Phone Use Linked to Higher Heart Disease Risk
Study links cell phone calls, at least weekly, sleep disruption, and physicological distress to heart disease.
Latest News
How ‘Oatzempic’ Stacks up to Ozempic
TikTok-based trend claims to be effective for losing weight, but does not provide benefits like GLP-1s.
Latest News
Skip Potassium After Cardiac Surgery
Postoperative atrial fibrillation risks is not altered with potassium supplementation for patients who recently had CV surgery, says study.
Conference Coverage
Timing of Blood Pressure Dosing Doesn’t Matter (Again): BedMed and BedMed-Frail
There was no cardiovascular mortality advantage to bedtime dosing, but neither was there any signal of safety concerns.
From the Journals
Stroke Risk from Atrial Fibrillation Rises in Presence of Rheumatoid Arthritis
The presence of rheumatoid arthritis increased the risk for stroke in patients with atrial fibrillation, a retrospective study showed.
Commentary
Delayed Bleeding: The Silent Risk for Seniors
The way that it did change my care was to give good return precautions to patients, to make sure they have somebody with them to say, “Hey,...
Commentary
The Wellness Industry: Financially Toxic, Says Ethicist
The money coming out of people’s pockets for wellness products could be used for the payment of things that we know work.
Commentary
Are Beta-Blockers Needed Post MI? No, Even After the ABYSS Trial
ABYSS is consistent with REDUCE-AMI, says doctor; stopping beta-blockers at 1 year did not increase death, MI, or stroke.
Latest News
Setbacks Identified After Stopping Beta-Blockers
Though halting beta-blockers does not increase stroke, death, or MI, CV hospitalization rates, BP, and HR were increased.
Latest News
Can Endurance Exercise Be Harmful?
A 2023 study found plaque burden and coronary stenoses were higher in lifelong athletes compared with controls.